← Evidence map

ArticleGut2022

CXCR2 inhibition enables NASH-HCC immunotherapy.

Jack Leslie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

138 papers cite itlatest 60 shown

2022
…
2023
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35477863